High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS
- 1 April 2004
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (3) , 243-247
- https://doi.org/10.1016/j.ejso.2003.11.004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Consensus Conference on the Classification of Ductal Carcinoma of the Breast, April 22–25, 1999Cancer, 2000
- The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 1999
- Prognostic factors in ductal carcinoma in situ of the breast: results of a retrospective study of 575 casesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
- Predictors of local recurrence after treatment of ductal carcinoma in situCancer, 1999
- p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breastEuropean Journal Of Cancer, 1997
- A prognostic index for ductal carcinoma in situ of the breastCancer, 1996
- Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breastEuropean Journal Of Cancer, 1995
- Prognostic classification of breast ductal carcinoma-in-situThe Lancet, 1995
- Heterogeneity of duct carcinoma in situ (DCIS): Relationship of grade and subtype analysis to local recurrence and risk of invasive transformationCancer Letters, 1995
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993